Global Biodegradable Implantable Drug Delivery System Market Research Report 2025

Publication ID:

PB505252497

Publication Date:

May 16, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Biodegradable Implantable Drug Delivery System was valued at US$ 1286 million in the year 2024 and is projected to reach a revised size of US$ 1923 million by 2031, growing at a CAGR of 6.0% during the forecast period.
A biodegradable implantable drug delivery system is a medical device or drug delivery system that is made of biodegradable materials and can be implanted into the human or animal body for sustained release of drugs or therapeutic substances, and then gradually decomposes into biodegradable materials. Absorbed components that are ultimately completely metabolized or eliminated by the organism
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biodegradable Implantable Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodegradable Implantable Drug Delivery System.
The Biodegradable Implantable Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biodegradable Implantable Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biodegradable Implantable Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Abbive
TerSera Therapeutics
Azurity
Simcere
Intersect ENT
Clinuvel
Innocoll Biotherapeutics
Segment by Type
Subcutaneous Implant Type
Injection Implant Type
Other
Segment by Application
Tumor
Ophthalmology
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biodegradable Implantable Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biodegradable Implantable Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Biodegradable Implantable Drug Delivery System Market Overview
1.1 Product Definition
1.2 Biodegradable Implantable Drug Delivery System by Type
1.2.1 Global Biodegradable Implantable Drug Delivery System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Subcutaneous Implant Type
1.2.3 Injection Implant Type
1.2.4 Other
1.3 Biodegradable Implantable Drug Delivery System by Application
1.3.1 Global Biodegradable Implantable Drug Delivery System Market Value by Application (2024 VS 2031)
1.3.2 Tumor
1.3.3 Ophthalmology
1.3.4 Other
1.4 Global Biodegradable Implantable Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Biodegradable Implantable Drug Delivery System Revenue 2020-2031
1.4.2 Global Biodegradable Implantable Drug Delivery System Sales 2020-2031
1.4.3 Global Biodegradable Implantable Drug Delivery System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biodegradable Implantable Drug Delivery System Market Competition by Manufacturers
2.1 Global Biodegradable Implantable Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biodegradable Implantable Drug Delivery System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biodegradable Implantable Drug Delivery System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biodegradable Implantable Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biodegradable Implantable Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biodegradable Implantable Drug Delivery System, Product Type & Application
2.7 Global Key Manufacturers of Biodegradable Implantable Drug Delivery System, Date of Enter into This Industry
2.8 Global Biodegradable Implantable Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global Biodegradable Implantable Drug Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biodegradable Implantable Drug Delivery System Players Market Share by Revenue
2.8.3 Global Biodegradable Implantable Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biodegradable Implantable Drug Delivery System Market Scenario by Region
3.1 Global Biodegradable Implantable Drug Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biodegradable Implantable Drug Delivery System Sales by Region: 2020-2031
3.2.1 Global Biodegradable Implantable Drug Delivery System Sales by Region: 2020-2025
3.2.2 Global Biodegradable Implantable Drug Delivery System Sales by Region: 2026-2031
3.3 Global Biodegradable Implantable Drug Delivery System Revenue by Region: 2020-2031
3.3.1 Global Biodegradable Implantable Drug Delivery System Revenue by Region: 2020-2025
3.3.2 Global Biodegradable Implantable Drug Delivery System Revenue by Region: 2026-2031
3.4 North America Biodegradable Implantable Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Biodegradable Implantable Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biodegradable Implantable Drug Delivery System Sales by Country (2020-2031)
3.4.3 North America Biodegradable Implantable Drug Delivery System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biodegradable Implantable Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Biodegradable Implantable Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biodegradable Implantable Drug Delivery System Sales by Country (2020-2031)
3.5.3 Europe Biodegradable Implantable Drug Delivery System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biodegradable Implantable Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific Biodegradable Implantable Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biodegradable Implantable Drug Delivery System Sales by Region (2020-2031)
3.6.3 Asia Pacific Biodegradable Implantable Drug Delivery System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biodegradable Implantable Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Biodegradable Implantable Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biodegradable Implantable Drug Delivery System Sales by Country (2020-2031)
3.7.3 Latin America Biodegradable Implantable Drug Delivery System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biodegradable Implantable Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Biodegradable Implantable Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biodegradable Implantable Drug Delivery System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biodegradable Implantable Drug Delivery System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biodegradable Implantable Drug Delivery System Sales by Type (2020-2031)
4.1.1 Global Biodegradable Implantable Drug Delivery System Sales by Type (2020-2025)
4.1.2 Global Biodegradable Implantable Drug Delivery System Sales by Type (2026-2031)
4.1.3 Global Biodegradable Implantable Drug Delivery System Sales Market Share by Type (2020-2031)
4.2 Global Biodegradable Implantable Drug Delivery System Revenue by Type (2020-2031)
4.2.1 Global Biodegradable Implantable Drug Delivery System Revenue by Type (2020-2025)
4.2.2 Global Biodegradable Implantable Drug Delivery System Revenue by Type (2026-2031)
4.2.3 Global Biodegradable Implantable Drug Delivery System Revenue Market Share by Type (2020-2031)
4.3 Global Biodegradable Implantable Drug Delivery System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biodegradable Implantable Drug Delivery System Sales by Application (2020-2031)
5.1.1 Global Biodegradable Implantable Drug Delivery System Sales by Application (2020-2025)
5.1.2 Global Biodegradable Implantable Drug Delivery System Sales by Application (2026-2031)
5.1.3 Global Biodegradable Implantable Drug Delivery System Sales Market Share by Application (2020-2031)
5.2 Global Biodegradable Implantable Drug Delivery System Revenue by Application (2020-2031)
5.2.1 Global Biodegradable Implantable Drug Delivery System Revenue by Application (2020-2025)
5.2.2 Global Biodegradable Implantable Drug Delivery System Revenue by Application (2026-2031)
5.2.3 Global Biodegradable Implantable Drug Delivery System Revenue Market Share by Application (2020-2031)
5.3 Global Biodegradable Implantable Drug Delivery System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbive
6.1.1 Abbive Company Information
6.1.2 Abbive Description and Business Overview
6.1.3 Abbive Biodegradable Implantable Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbive Biodegradable Implantable Drug Delivery System Product Portfolio
6.1.5 Abbive Recent Developments/Updates
6.2 TerSera Therapeutics
6.2.1 TerSera Therapeutics Company Information
6.2.2 TerSera Therapeutics Description and Business Overview
6.2.3 TerSera Therapeutics Biodegradable Implantable Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 TerSera Therapeutics Biodegradable Implantable Drug Delivery System Product Portfolio
6.2.5 TerSera Therapeutics Recent Developments/Updates
6.3 Azurity
6.3.1 Azurity Company Information
6.3.2 Azurity Description and Business Overview
6.3.3 Azurity Biodegradable Implantable Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Azurity Biodegradable Implantable Drug Delivery System Product Portfolio
6.3.5 Azurity Recent Developments/Updates
6.4 Simcere
6.4.1 Simcere Company Information
6.4.2 Simcere Description and Business Overview
6.4.3 Simcere Biodegradable Implantable Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Simcere Biodegradable Implantable Drug Delivery System Product Portfolio
6.4.5 Simcere Recent Developments/Updates
6.5 Intersect ENT
6.5.1 Intersect ENT Company Information
6.5.2 Intersect ENT Description and Business Overview
6.5.3 Intersect ENT Biodegradable Implantable Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Intersect ENT Biodegradable Implantable Drug Delivery System Product Portfolio
6.5.5 Intersect ENT Recent Developments/Updates
6.6 Clinuvel
6.6.1 Clinuvel Company Information
6.6.2 Clinuvel Description and Business Overview
6.6.3 Clinuvel Biodegradable Implantable Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Clinuvel Biodegradable Implantable Drug Delivery System Product Portfolio
6.6.5 Clinuvel Recent Developments/Updates
6.7 Innocoll Biotherapeutics
6.7.1 Innocoll Biotherapeutics Company Information
6.7.2 Innocoll Biotherapeutics Description and Business Overview
6.7.3 Innocoll Biotherapeutics Biodegradable Implantable Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Innocoll Biotherapeutics Biodegradable Implantable Drug Delivery System Product Portfolio
6.7.5 Innocoll Biotherapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biodegradable Implantable Drug Delivery System Industry Chain Analysis
7.2 Biodegradable Implantable Drug Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biodegradable Implantable Drug Delivery System Production Mode & Process Analysis
7.4 Biodegradable Implantable Drug Delivery System Sales and Marketing
7.4.1 Biodegradable Implantable Drug Delivery System Sales Channels
7.4.2 Biodegradable Implantable Drug Delivery System Distributors
7.5 Biodegradable Implantable Drug Delivery System Customer Analysis
8 Biodegradable Implantable Drug Delivery System Market Dynamics
8.1 Biodegradable Implantable Drug Delivery System Industry Trends
8.2 Biodegradable Implantable Drug Delivery System Market Drivers
8.3 Biodegradable Implantable Drug Delivery System Market Challenges
8.4 Biodegradable Implantable Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbive
TerSera Therapeutics
Azurity
Simcere
Intersect ENT
Clinuvel
Innocoll Biotherapeutics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂